Arlington Capital Partners Makes Majority Growth Investment in CBSET

Arlington Capital Partners Makes Majority Investment in Everest Clinical Research Corporation

December 7, 2020

Healthcare Services

Washington, D.C.-based private equity firm Arlington Capital Partners has made a majority investment in Toronto-headquartered Everest Clinical Research Corporation, with Everest's founding shareholders and senior management rolling equity and continuing to lead the company. Everest is a full-service contract research organization (CRO) with ~300 employees across Toronto, Little Falls (NJ) and Shanghai; Arlington will support expansion of service lines, capabilities and headcount to drive growth.

Arlington Capital Partners Makes Majority Investment in Afton Scientific

January 30, 2024

Pharmaceuticals

Arlington Capital Partners has made a majority investment in Afton Scientific, a Charlottesville-based CDMO specializing in sterile injectable drug manufacturing and related lab/packaging services. The partnership will support Afton's capacity growth and expansion of service offerings while founder and CEO Tom Thorpe remains a material shareholder and will continue to lead the company.

Arlington Capital Partners Acquires TEAM Technologies

November 26, 2024

Medical Devices

Arlington Capital Partners has acquired TEAM Technologies, a Morristown, Tennessee–headquartered medical device manufacturer and strategic supply‑chain solutions provider, from Clearlake Capital Group for an undisclosed sum. Arlington plans to build on TEAM Tech’s vertically integrated manufacturing footprint and accelerate growth through organic investment and strategic add‑on M&A to strengthen healthcare supply chains and customer capabilities.

Everest Clinical Research (Arlington) Acquires August Research

November 7, 2023

Healthcare Services

Everest Clinical Research, a portfolio company of Arlington Capital Partners, has acquired European contract research organization August Research. The deal expands Everest's European footprint and clinical trial (CTS) and pharmacovigilance (PV) capabilities across 14 countries; August's founders will remain with the business. Financial terms were not disclosed.

Ampersand Capital Partners Makes Growth Investment in Lexington Medical

April 17, 2025

Medical Devices

Ampersand Capital Partners has made a strategic growth investment in Lexington Medical, a Bedford, Massachusetts-based designer and manufacturer of minimally invasive surgical stapling devices. The investment will support Lexington's product innovation, smart manufacturing initiatives, and global market expansion while bolstering the company's US-based manufacturing and talent base.

Edgewater Capital Partners Invests in CBCC Global Research

May 27, 2025

Healthcare Services

Edgewater Capital Partners, a Cleveland-based private equity firm, has partnered with the shareholders and management of CBCC Global Research, a Bakersfield-headquartered clinical contract research organization (CRO). Edgewater's investment will support CBCC's growth by funding people, technology, and infrastructure to expand its clinical trial services across oncology, CNS, ophthalmology and other therapeutic areas.